Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared a post on LinkedIn:
“It was a pleasure to attend the International Society on Thrombosis and Haemostasis (ISTH) 2026 and meet many colleagues, collaborators, and scientists working across the fields of hemostasis and thrombosis.
During the meeting, I presented our data on whole-exome sequencing in patients with low von Willebrand factor and also had the opportunity to discuss our work on estimating the global and population prevalence of coagulation disorders using large-scale genomic databases at the ISTH SSC Omics session.
It was a great week of science, discussions, and new ideas, and I look forward to seeing how these conversations develop in the coming years.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD